| Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More | Frank Vinluan | 04/24/20 | National |
| Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec | Sarah de Crescenzo | 04/22/20 | Seattle |
| Synthorx Gets $131M in Upsized IPO for Synthetic Biology Drugs | Sarah de Crescenzo | 12/07/18 | San Diego |
| Synthorx Files for IPO to Advance Enhanced Cytokine Drugs | Sarah de Crescenzo | 11/14/18 | San Diego |
| Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs | Bruce V. Bigelow | 04/30/18 | San Diego |
| Cleave Bio Gets $37M From Celgene, Others For Clinical Push | David Holley | 08/08/16 | San Francisco |
| With $2M Seed, Perlstein Lab Tests Unorthodox Rare-Disease Plan | Alex Lash | 07/31/14 | San Francisco |
| Big Data, Big Biology, and the ‘Tipping Point’ in Quantified Health | Bruce V. Bigelow | 04/26/12 | San Diego |
| Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies | Luke Timmerman | 10/11/11 | San Francisco |
| Phenomix, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Labs Walks | Luke Timmerman | 10/26/10 | San Diego |
| Anaphore Names 2 to Board | Bruce V. Bigelow | 06/15/10 | San Diego |
| Phenomix Diabetes Drug Dumped by Forest Labs, After Hitting Clinical Trial Goals | Luke Timmerman | 04/20/10 | San Diego |
| Phenomix Strikes European Partnership for Diabetes Drug, Potentially Worth $163M | Luke Timmerman | 12/02/09 | San Diego |
| SynergEyes Gets $13.3M, Carl Icahn Aims to Shake Up BiogenIdec Board, Layoffs Mount, & More San Diego BizTech News | Bruce V. Bigelow | 02/09/09 | San Diego |
| Phenomix Aims to Grab Piece of $10 Billion Diabetes Market | Luke Timmerman | 02/04/09 | San Diego |
| Five Questions for the Future of Biotech in San Diego, Part 2 | Luke Timmerman | 01/21/09 | San Diego |
| Five Questions for the Future of Biotech in San Diego, Part 1 | Luke Timmerman | 01/20/09 | San Diego |
